SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001557142-20-000029
Filing Date
2020-05-07
Accepted
2020-05-07 16:28:22
Documents
72
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kdmn-20200331x10q.htm 10-Q 1058037
2 EX-31.1 kdmn-20200331xex31_1.htm EX-31.1 20172
3 EX-31.2 kdmn-20200331xex31_2.htm EX-31.2 20265
4 EX-32.1 kdmn-20200331xex32_1.htm EX-32.1 10112
5 EX-32.2 kdmn-20200331xex32_2.htm EX-32.2 9950
  Complete submission text file 0001557142-20-000029.txt   4757564

Data Files

Seq Description Document Type Size
6 EX-101.INS kdmn-20200331.xml EX-101.INS 850760
7 EX-101.SCH kdmn-20200331.xsd EX-101.SCH 43698
8 EX-101.CAL kdmn-20200331_cal.xml EX-101.CAL 45411
9 EX-101.DEF kdmn-20200331_def.xml EX-101.DEF 192388
10 EX-101.LAB kdmn-20200331_lab.xml EX-101.LAB 346298
11 EX-101.PRE kdmn-20200331_pre.xml EX-101.PRE 320072
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37841 | Film No.: 20856910
SIC: 2834 Pharmaceutical Preparations